首页 | 本学科首页   官方微博 | 高级检索  
检索        

羟基喜树碱膀胱灌注预防膀胱癌术后复发
引用本文:陈贵平,赵阳,曹浩明,姜海,史时芳.羟基喜树碱膀胱灌注预防膀胱癌术后复发[J].肿瘤防治研究,2000,27(6):479-480.
作者姓名:陈贵平  赵阳  曹浩明  姜海  史时芳
作者单位:1. 浙江省肿瘤医院三病区,杭州,310022
2. 浙江大学附属第一医院泌尿外科
摘    要: 目的 评估膀胱灌注羟基喜树碱预防膀胱癌术后复发的疗效。方法 应用羟基喜树碱膀胱灌注预防膀胱癌术后复发并与MMC进行随机对照观察。结果 羟基喜树碱组治疗 2 3例 ,随访 6~ 36个月 ,复发 3例 ,复发率为 13 0 %。而MMC组治疗 2 2例 ,随访 7~ 36个月 ,复发 4例 ,复发率为 18 2 %。结论 提示HCPT的疗效与MMC相仿 ,而副作用明显减少 ,认为羟基喜树碱是目前预防膀胱癌术后复发较理想的药物之一。

关 键 词:膀胱肿瘤  羟基喜树碱  预防复发
收稿时间:1999-10-24;
修稿时间:1999-10-24

Intravesical Instillation of HCPT to Prevent Recurrence after Surgery for Bladder Cancer
CHEN Guai-ping,ZAO·Yang,CHAO Hao-ming,et al.Intravesical Instillation of HCPT to Prevent Recurrence after Surgery for Bladder Cancer[J].Cancer Research on Prevention and Treatment,2000,27(6):479-480.
Authors:CHEN Guai-ping  ZAO·Yang  CHAO Hao-ming  
Institution:Zhejiang cancer Hospital; Hangzhou 310022; China;
Abstract:Objective To evalute the results of intravesical HCPT instillation to prevent recurrence after surgery for bladder cancer.Methods A randomized and placebo-controlled trial on intravesical HCPT instillation versus MMC therapy for recurrence prevention in post operative bladder cancer patients was carried out.Results Twnty-three patients were treated with HCPT with.23 followed for 6 to 36 months.Three patients developed recurrence,recurrent rate was 13.0%.Twenty-two.patients were treated with MMC with 22 followed for 7 to 36 months.Four patients developed recurrence,recurrent rate was 18.2%.Conclusion There is little different between HCPT with MMC on results.but,HCPT has milder side effects.HCPT is believed to be one of the effective drugs in preventing bladder cancer recurrence after surgery.
Keywords:s:Bladder neoplasms  HCPT  Prevent recurrence  \  
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号